Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects
This study has been completed.
Study NCT01489774   Information provided by CJ Cheiljedang Corporation

First Received on November 9, 2011.   Last Updated on August 1, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Digestive System Diseases
Additional conditions recognized in this trial
Gastrointestinal Diseases
Interventions listed in this trial
Placebo
CJ-12406
Sponsors listed in this trial
CJ Cheiljedang Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services